Oncocorner

Webinar

Oct
2025

00
CET

Tumour sites CME application in progress

How to decide on treatment strategies for high-risk early HR+/HER2- breast cancer

This webinar will address treatment strategies for high-risk early HR+/HER2- breast cancer, with a focus on the evolving role of CDK4/6 inhibitors. Experts will discuss clinical endpoints, practical considerations for safe and effective use, and the balance between efficacy and individualised care.

Speakers

Discussant

Aapro Matti

Sharing Progress in Cancer Care and Clinique de Genolier, Bellinzona and Genolier, Switzerland

Expert

Barrios Carlos

Oncoclinicas Group, Hospital São Lucas, Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil

Expert

Harbeck Nadia

Breast Center, LMU University Hospital, Munich, Germany